Email: wangrun18887308999@163.com

Address: A-526

Ph.D Candidate from Fudan University (2021.09-2025.06)

M.S. from Shanghai Institute of Materia Medica Chinese Academy of Sciences (2018-2021)

B.S. fromBeijing Institute of Technology (2014-2018)

Research project: Theranostics using Stimuli-triggered in situ self-assembly approach, Medicinal Chemistry

教育经历：

l  2021.09-2025.06: 复旦大学药学院 博士（导师：柳红研究员、叶德举教授）

l  2018.07-2021.07: 中国科学院上海药物研究所 硕士（导师：柳红研究员）

l  2014.09-2018.06: 北京理工大学制药工程专业学士

获奖情况:

l  2017年获得华瑞世纪奖学金

l  2018年获得北京市优秀毕业生

l  2018年获得中国科学院大学大学生奖学金

l  2022年复旦大学优秀学业奖学金

l  2024年复旦大学优秀学业奖学金

发表文章：

1. Run Wang, Xiong Xie, Hong Liu, et al. Rh(III)-Catalyzed C–H Bond Activation for the Construction of Heterocycles with sp3-Carbon Centers [J]. Catalysts, 2019, 9(10).

2. Hou X^#, Wang R^#, Zhou J, et al. Substrate- and Catalyst-Controlled C−H Bond Activation/Annulation for Construction of Pyrido[2,3,4-de]quinazolinones and Indolo[1,2-c]quinazolinones[J], 2024, 366(1): 134-140.

3. Hou X^#, Wang R^#, Fang F, et al. Rh(III)-Catalyzed C–H Activation/Annulation for the Construction of Quinolizinones and Indolizines[J]. Organic Letters, 2024, 26(21): 4451-4456.

4. Jiyuan Li, Feifei Fang, Run Wang, Yuan Li, Bin Xu, Hong Liu, and Yu Zhou. Rh(III)-Catalyzed C-H Activation/Regiospecific Annulation Cascade of Benzoic acids with Propargyl Acetates to Unusual 3-Alkylidene-Isochromanones.Org. Chem. Front., 2021,8, 3876-3882